{
    "Title": "Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model",
    "URL": "https://doi.org/10.1371/journal.pntd.0005942",
    "Published": "September 21, 2017",
    "Subject_Areas": [
        "Portal veins",
        "Schistosoma mansoni",
        "Mouse models",
        "Blood plasma",
        "Metabolites",
        "Pediatric infections",
        "Pharmacokinetics",
        "Routes of administration"
    ],
    "Authors": {
        "Nada Abla": [
            "Merck Global Health Institute, Ares Trading S.A., a subsidiary of Merck KGaA (Darmstadt, Germany), Coinsins, Switzerland",
            "Medicines for Malaria Venture, Geneva, Switzerland"
        ],
        "Jennifer Keiser": [
            "Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland",
            "University of Basel, Basel, Switzerland"
        ],
        "Mireille Vargas": [
            "Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland",
            "University of Basel, Basel, Switzerland"
        ],
        "Natalie Reimers": [
            "helminGuard, Research Center Borstel, Borstel, Germany"
        ],
        "Helmut Haas": [
            "helminGuard, Research Center Borstel, Borstel, Germany"
        ],
        "Thomas Spangenberg": [
            "Merck Global Health Institute, Ares Trading S.A., a subsidiary of Merck KGaA (Darmstadt, Germany), Coinsins, Switzerland"
        ]
    }
}